. 2019 May 9;20(1):182–190. doi: 10.3892/mmr.2019.10219

Table II.

Association of FER1L4 with clinicopathological characteristics among 100 patients with lung cancer.

		Expression of FER1L4

Clinicopathological characteristics	Number of patients	Low, n=57	High, n=43	P-value
Age, years				0.958
<40	15	8	7
40–50	23	13	10
>50	62	36	26
Sex				0.683
Male	60	33	27
Female	40	24	16
Presenting symptoms				0.121
Painless lump	41	20	21
Painful lump	35	19	16
Atypical symptoms	24	18	6
Tumor size, T				<0.001^a
T1, ≤2 cm	17	3	14
T2, >2 cm but <5 cm	32	14	18
T3, ≥5 cm	28	20	8
T4, any size with distant metastasis	23	20	3
Lymph node metastasis, N				0.001^a
N0	45	17	28
N1 or above	55	40	15
Distant metastasis, M				0.002^a
M0	42	16	26
M1	58	41	17
TNM stage				<0.001^a
I/II	34	10	24
III/IV	66	47	19

P<0.05. TNM, tumor, node and metastasis; FER1L4, Fer-1-like family member 4.